<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 7 Issue 1</issue_number>
<issue_period>2016 (January - March)</issue_period>
<title>CROMOLYN INHIBITS 7, 12-DIMETHYLBENZ (A) ANTHRACENE INDUCED ORAL CANCER THROUGH APOPTOTIC INDUCTION AND SUPPRESSION OF CELL PROLIFERATION </title>
<abstract>The present study evaluated the effect of cromolyn on the expression pattern of genes involved in the process of apoptosis (P lessThan sup greaterThan 53 lessThan /sup greaterThan , Bcl-2, Bax, Bcl-xL and Bad) and cell proliferation (PCNA, Cyclin D1, CDK4, CDK6 and Survivin) during 7,12-dimethylbenz(a)anthracene (DMBA)induced hamster buccal pouch carcinogenesis. Hamsters buccal pouches exposed to 0.5% DMBA in liquid paraffin, three times a week for 14 weeks, developed well differentiated squamous cell carcinoma. Administration of cromolyn at a dose of 80mg/kg b.w orally to hamsters treated with DMBA not only prevented the tumor formation but also induced apoptosis and suppressed cell proliferation. Thus, the apoptotic and anti-cell proliferative efficacy of cromolyn might have suppressed DMBA induced tumorgenesis in the buccal pouches of golden Syrian hamsters</abstract>
<authors>SEKAR KARTHIKEYAN AND SHANMUGAM MANOHARAN</authors>
<keywords>Oral cancer, apoptosis, cell proliferation and cromolyn</keywords>
<pages>35-42</pages>
</article>
</Journal>
